Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia
Science Advances · 17.01.2025 · 11 (3)
DOI: 10.1126/sciadv.adp8494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 17.01.2025. Verfasst von Hiroyuki Neyama und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-00…. Hauptthemen laut MEDLINE: Analgesia, Receptors, Opioid, mu, Analgesics, Opioid, Neuralgia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Placebo analgesia is caused by inactive treatment, implicating endogenous brain function involvement. However, the neurobiological basis remains unclear. In this study, we found that μ-opioid signals in the medial prefrontal cortex (mPFC) activate the descending pain inhibitory system to initiate placebo analgesia in neuropathic pain rats. Chemogenetic manipulation demonstrated that specific activation of μ-opioid receptor–positive (MOR + ) neurons in the mPFC or suppression of the mPFC–ventrolateral periaqueductal gray (vlPAG) circuit inhibited placebo analgesia in rats. MOR + neurons in the mPFC are monosynaptically connected and directly inhibit layer V pyramidal neurons that project to the vlPAG via GABA A receptors. Thus, intrinsic opioid signaling in the mPFC disinhibits excitatory outflow to the vlPAG by suppressing MOR + neurons, leading to descending pain inhibitory system activation that initiates placebo analgesia. Our results shed light on the fundamental neurobiological mechanism of the placebo effect that maximizes therapeutic efficacy and reduces adverse drug effects in medical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, 6-7-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
- Multiomics Platform, Center for Cancer Immunotherapy and Immunobiology, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
- Department of Pharmacology, Nihon University School of Dentistry, 1-8-13 Kanda Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan.
- Department of Molecular Genetics, Fukushima Medical University Institute of Biomedical Sciences, 1 Hikariga-oka, Fukushima 960-1295, Japan.
- Laboratory for Comparative Connections, RIKEN Center for Biosystems Dynamics Research, 2-2-3 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.
- Division of Laboratory Animal Research, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan.
ORCID-Profile: Hiroyuki Neyama, Yuping Wu, Shigeki Kato, Tsuyoshi Tahara, Mika Shigeta, Michiko Inoue, Kazunari Miyamichi, Natsuki Matsushita, Tomoji Mashimo, Yoshiki Miyasaka, Yi Dai, Koichi Noguchi, Kazuto Kobayashi, Yilong Cui
Zitieren
APA
Neyama, H., Wu, Y., Nakaya, Y., Kato, S., Shimizu, T., Tahara, T., Shigeta, M., Inoue, M., Miyamichi, K., Matsushita, N., Mashimo, T., Miyasaka, Y., Dai, Y., Noguchi, K., Watanabe, Y., Kobayashi, M., Kobayashi, K., & Cui, Y. (2025). Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia. Science Advances, 11(3). https://doi.org/10.1126/sciadv.adp8494
Vancouver
Neyama H, Wu Y, Nakaya Y, Kato S, Shimizu T, Tahara T, et al. Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia. Science Advances. 2025;11(3). doi:10.1126/sciadv.adp8494
BibTeX
@article{Neyama2025,
author = {Neyama, Hiroyuki and Wu, Yuping and Nakaya, Yuka and Kato, Shigeki and Shimizu, Tomoko and Tahara, Tsuyoshi and Shigeta, Mika and Inoue, Michiko and Miyamichi, Kazunari and Matsushita, Natsuki and Mashimo, Tomoji and Miyasaka, Yoshiki and Dai, Yi and Noguchi, Koichi and Watanabe, Yasuyoshi and Kobayashi, Masayuki and Kobayashi, Kazuto and Cui, Yilong},
title = {Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {3},
doi = {10.1126/sciadv.adp8494}
}
EUVIMED